Form 990 for tax year 2025
Filed by BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA.
Totals
- Total revenue
- $1,916,941
- Total expenses
- $6,802,870
- Contributions and grants received
- $337,002
- Grants paid
- $4,075,908
- Program service revenue
- $0
- Investment income
- $1,579,939
- Other revenue
- $0
- Total assets, end of year
- $13,199,021
- Total liabilities, end of year
- $231,996
- Net assets or fund balances, end of year
- $12,967,025
- Program services expenses (Part IX)
- $6,569,158
- Management and general expenses
- $223,801
- Fundraising expenses
- $9,911
- Program service expenses (Part III)
- $6,569,158
Program services were 96.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$337,002
-
1g · Noncash contributions included above
$36,640
-
3 · Investment income
total $1,579,939 · excluded $1,579,939
-
4 · Income from investment of tax-exempt bond proceeds
total $0
-
5 · Royalties
total $0
-
6d · Net rental income or loss
total $0
-
7d · Net gain or loss
total $0
-
8c · Net income from fundraising events
total $0
-
9c · Net income from gaming
total $0
-
10c · Net income from sales of inventory
total $0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $3,374,649 · program services $3,374,649
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $701,259 · program services $701,259
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $185,000 · program services $151,928 · management and general $28,347 · fundraising $4,725
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $148,887 · program services $121,210 · management and general $25,152 · fundraising $2,525
-
8 · Pension plan contributions
total $0
-
9 · Other employee benefits
total $22,205 · program services $18,234 · management and general $3,404 · fundraising $567
-
10 · Payroll taxes
total $25,472 · program services $20,968 · management and general $3,850 · fundraising $654
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $9,877 · program services $9,877
-
11c · Fees: accounting
total $63,466 · management and general $63,466
-
11d · Fees: lobbying
total $0
-
11e · Fees: professional fundraising services
total $0
-
11f · Fees: investment management
total $44,747 · management and general $44,747
-
11g · Fees: other
total $199,097 · program services $169,097 · management and general $30,000
-
12 · Advertising and promotion
total $0
-
13 · Office expenses
total $27,289 · program services $8,757 · management and general $18,056 · fundraising $476
-
14 · Information technology
total $0
-
15 · Royalties
total $0
-
16 · Occupancy
total $33,950 · program services $27,815 · management and general $5,331 · fundraising $804
-
17 · Travel
total $0
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $20,927 · program services $20,592 · management and general $335
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $0
-
23 · Insurance
total $7,047 · program services $5,774 · management and general $1,113 · fundraising $160
-
24a · Other expenses: Neurofilament surveillance
total $1,270,324 · program services $1,270,324
-
24b · Other expenses: Patient Identification
total $530,674 · program services $530,674
-
24c · Other expenses: Sponsorships
total $69,078 · program services $69,078
-
24d · Other expenses: Other scientific expenses
total $68,922 · program services $68,922
-
24e · All other expenses
total $0
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $119,051 · end of year $76,104
-
2 · Savings and temporary cash investments
beginning of year $367,150 · end of year $151,333
-
3 · Pledges and grants receivable
beginning of year $133,407 · end of year $121,984
-
4 · Accounts receivable
end of year $0
-
5 · Loans and receivables from officers and key people
end of year $0
-
6 · Loans and receivables from disqualified persons
end of year $0
-
7 · Other notes and loans receivable
end of year $0
-
8 · Inventories for sale or use
end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $120,599 · end of year $252,387
-
10c · Land, buildings and equipment, net
end of year $0
-
11 · Investments: publicly traded securities
beginning of year $17,400,372 · end of year $12,445,813
-
12 · Investments: other securities
end of year $0
-
13 · Investments: program-related
end of year $0
-
14 · Intangible assets
end of year $0
-
15 · Other assets
beginning of year $185,232 · end of year $151,400
-
17 · Accounts payable and accrued expenses
beginning of year $196,674 · end of year $111,160
-
25 · Other liabilities
beginning of year $90,995 · end of year $120,836
-
27 · Net assets without donor restrictions
beginning of year $18,038,142 · end of year $12,967,025
Mission and programs · 2025
Mission
frontal lobe of the brain and may extend back to the temporal lobe. FTD is the second most common early-onset dementia after Alzheimer's disease.
Activities or mission (Part I)
The Organization's primary mission is to help find a cure for Frontotemporal dementia (FTD). The Bluefield Project was founded by a family group whose lives have been directly impacted by FTD. FTD is a clinical syndrome caused by degeneration of the [continued on page 2]
-
The Bluefield Project is an effort to find a treatment or cure for frontotemporal dementia (FTD) by funding FTD-related research. By privately funding basic, translational and clinical FTD-related research, the donor group that established The Bluefield Project has significantly increased the number of labs studying FTD. THE BLUEFIELD RESEARCH CONSORTIUM, FUNDED BY THE BLUEFIELD PROJECT, APPLIES A BUSINESS MODEL TO RESEARCH BY INCENTIVIZING THE SHARING OF DATA AND REAGENTS, THEREBY ACCELERATING DISCOVERY. FTD ENCOMPASSES A GROUP OF COMPLEX NEURODEGENERATIVE DISEASES CHARACTERIZED BY PROGRESSIVE DETERIORATION OF THE FRONTOTEMPORAL LOBES AND RESULTANT LOSS OF DECISION-MAKING ABILITIES AND CONTROL OF BEHAVIOR, EMOTION, AND LANGUAGE.
Expenses $6,569,158 · Grants $4,075,908
As filed on the 2025 return.
Listed in Part VII
-
Robert V Farese Jr MD
Director
- Total calculated
- $466,613
- From this org
- $466,613
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
Schedule J breakdown matched by us
- Base
- not reported
- Bonus
- not reported
- Other
- $466,613
- Deferred
- not reported
- Nontaxable benefits
- not reported
- Filer's total
- $466,613
-
Bruce Miller MD
Director
- Total calculated
- $410,000
- From this org
- $410,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
Schedule J breakdown matched by us
- Base
- $10,000
- Bonus
- not reported
- Other
- $400,000
- Deferred
- not reported
- Nontaxable benefits
- not reported
- Filer's total
- $410,000
-
Laura Mitic
President
- Total calculated
- $225,000
- From this org
- $225,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 20 + 20 related
Schedule J breakdown matched by us
- Base
- $185,000
- Bonus
- $40,000
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- not reported
- Filer's total
- $225,000
-
Alexandra Nicholson
Dir Research Pship
- Total calculated
- $171,092
- From this org
- $148,887
- From related orgs
- $0
- Other
- $22,205
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $138,887
- Bonus
- $10,000
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $22,205
- Filer's total
- $171,092
-
Ian Massey PhD
Director
- Total calculated
- $10,000
- From this org
- $10,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
Schedule J breakdown matched by us
- Base
- $10,000
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- not reported
- Filer's total
- $10,000
-
Robin Richards Donohoe
Board Chair
- Total calculated
- $0
- Hours/week
- 2
-
Christopher Donohoe
Secty/Treasurer
- Total calculated
- $0
- Hours/week
- 0.5
-
Roy Richards Jr
Director
- Total calculated
- $0
- Hours/week
- 1
-
Williamson Bradford MD
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Karen Chen PhD
Director
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- Part II, Compensation from Unrelated Organizations
- Bluefield provides funding to certain outside unrelated medical research institutions. Certain amounts provided to these organizations (from Bluefield) are used to compensate researchers, some of whom sit on the Board of Directors of Bluefield. As a result of this arrangement, Bluefield has taken the position that such compensation must be reflected in the tax return as compensation from a related organization.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$2,288,519
Research
-
$466,613
Research
-
$274,517
Research
-
University of Alabama
$180,000
Research
-
$165,000
Research
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- —
- Employees, agents and contractors (line 3c)
- 4
- Expenditures and investments (line 3c)
- $701,259
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| Europe | 0 | 4 | Funding Medical Research | Clinical Medicine Grants | $701,259 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| Europe | $262,240 | Wire | — | — | Actual Cost |
| Europe | $305,386 | Wire | — | — | Actual Cost |
| Europe | $64,423 | Wire | — | — | Actual Cost |
| Europe | $69,210 | Wire | — | — | Actual Cost |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- —
- Other grantees (Part II line 3)
- 4
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2025
- Filed
- 7 July 2026
- IRS schema version
- 2025v4.1
- Source object
- 202641889349301349
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.